Vascular Biogenics News Timeline

Vascular Biogenics Ltd -- USA Stock  

USD 6.9  0.2  2.99%

This is yet another view into Vascular Biogenics filtered headlines to help investors concentrate on Vascular Biogenics Ltd noise-free news that matters. Some academic researchers believe in strong correlation between financial news and their impacts to the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Vascular Biogenics headlines in addition to utilizing other more conventional financial analysis modules. Also please take a look at Vascular Biogenics Backtesting and Vascular Biogenics Hype Analysis
December 13, 2017
TherapeuticsMD, Inc. is at 6.80 per share and Vascular Biogenics Ltd ... at 
View Story
Equities News
December 14, 2017
NantKwest Inc. Plunges 6.14 percent on December 14 at 
View Story
nasdaq News
December 15, 2017
DelMar Pharmaceuticals, Inc. - Stocks Luring Investors Focus at 
View Story
Macroaxis News
December 13, 2017
Purchase by Jeff Baxter of 4609 shares of VBI Vaccines at MacroaxisInsider 
View Story